Status:
COMPLETED
Specialist Recommendation on FBC (Familial Breast Cancer) Chemoprevention Prescribing
Lead Sponsor:
University of Nottingham
Collaborating Sponsors:
University of Oxford
Conditions:
Familial Breast Cancer
Eligibility:
All Genders
Brief Summary
Some women are more likely to get breast cancer as it runs in their family, they are at risk of familial breast cancer. There are medications, called chemoprevention, which may lower their risk of dev...
Detailed Description
Phase I: Short survey of lead clinicians of familial cancer services, descriptive analysis of recommendations by areas of the country Phase II: Prescribing data analysis (using OpenPrescribing) compr...
Eligibility Criteria
Inclusion
- Lead clinicians of NHS familial cancer services across England
- Standard general practices (classed as type 4 by NHS Digital, to exclude walk-in centres, prisons, care homes, etc.) with prescribing data for chemoprevention available on OpenPrescribing
Exclusion
- General practices with less than 10 female patients aged 35 to 44 registered
- General practices which cannot be linked to any familial cancer service from survey responses
Key Trial Info
Start Date :
July 22 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2019
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04058418
Start Date
July 22 2019
End Date
December 31 2019
Last Update
March 24 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Nottingham
Nottingham, United Kingdom